This is the authors' abstract. We don't add key points for this paper.
Significance Fragile X syndrome (FXS), the most prevalent monogenic form of autism, is caused by the loss of FMRP, an RNA binding protein. In the absence of FMRP, translation is dysregulated, but restoration of translational homeostasis rescues the syndrome and thus could suggest new treatments for the disorder. Using ribosome profiling and RNA metabolic profiling, we show that, in the FMRP-deficient mouse brain, there are few specific translational disturbances. Instead, there is widespread imbalance of RNA levels. This imbalance is caused by destabilization of the FMRP targets and other mRNAs based on codon optimality. Rebalancing the transcriptome may therefore be a key to correcting syndrome-related pathophysiologies. This study establishes a role for FMRP in linking codon optimality to RNA stability.
No takes yet. Share an insight, caveat, or question.
Shu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: